Ciprofloxacin increases serum clozapine and N-desmethylclozapine: A study in patients with schizophrenia

European Journal of Clinical Pharmacology

Volumn 56, Issue 8, 2000, Pages 585-589

  Raaska, K ^a   Neuvonen, P J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Ciprofloxacin; Clozapine; CYP1A2

Indexed keywords

ASCORBIC ACID; ATENOLOL; CHLORPROMAZINE; CIPROFLOXACIN; CLOZAPINE; CYTOCHROME P450; DIAZEPAM; LEVOMEPROMAZINE; LORAZEPAM; NAPROXEN; NORCLOZAPINE; PERPHENAZINE; PLACEBO; PROPRANOLOL; TEMAZEPAM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

ADULT; ANTI-INFECTIVE AGENTS; ANTIPSYCHOTIC AGENTS; CIPROFLOXACIN; CLOZAPINE; CROSS-OVER STUDIES; CYTOCHROME P-450 CYP1A2; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ENZYME INHIBITORS; FEMALE; HUMANS; INDIVIDUALITY; MALE; MIDDLE AGED; PLACEBOS; SCHIZOPHRENIA;

EID: 0033667335     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000192     Document Type: Article

References (23)

1. Clozapine: A review of its pharmacological properties and therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents
2. Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test
3. Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: Evidence from a therapeutic drug monitoring service
4. Characterisation of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine
5. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
6. Metabolism and bioactivation of clozapine by human liver in vitro
7. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine
8. N-oxygenation of clozapine by flavin-containing monooxygenase
9. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro
10. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum
11. The effects of quinolones on xanthine pharmacokinetics
12. Fluoroquinolone inhibition of clozapine metabolism
13. Rapid and sensitive determination of clozapine in human plasma using high-performance liquid chromatography and amperometric detection
14. The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography
15. Study of 4-quinolone antibiotics in biological samples by short-column liquid chromatography coupled with electrospray ionization tandem mass spectrometry
16. Effect of desmethylclozapine on fos protein expression in the forebrain: In vivo biological activity of the clozapine metabolite
17. Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients
18. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers
19. Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients
20. Serum concentration of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole
21. Absence of interaction between erythromycin and a single dose of clozapine
22. Disposition of clozapine in man: Lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms
23. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors